Risk Factors Associated with a First Exacerbation Among Patients with COPD Classified as GOLD A and B in Routine Clinical Practice in the UK

References

• WHO Chronic obstructive pulmonary disease (COPD); 2022. Available from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd). Accessed October 17, 2022.
   Google Scholar
• NICE Chronic obstructive pulmonary disease: how common is it?; 2023. Available from: https://cks.nice.org.uk/topics/chronic-obstructive-pulmonary-disease/background-information/prevalence-incidence/. Accessed October 17, 2022.
   Google Scholar
• British Lung Foundation Chronic obstructive pulmonary disease (COPD) statistics; 2022. Available from: https://statistics.blf.org.uk/copd. Accessed June 27, 2022.
   Google Scholar
• British lung foundation the battle for breath - the impact of lung disease in the UK; 2016. Available from: https://statistics.blf.org.uk/. Accessed June 27, 2022.
   Google Scholar
• Iheanacho I, Zhang S, King D, Rizzo M, Ismaila AS. Economic burden of chronic obstructive pulmonary disease (COPD): a systematic literature review. Int J Chron Obstruct Pulmon Dis. 2020;15:439–460. doi:10.2147/COPD.S234942
   PubMed Web of Science ®Google Scholar
• Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. doi:10.1056/NEJMoa0909883
   PubMed Web of Science ®Google Scholar
• Rothnie KJ, Müllerová H, Smeeth L, Quint JK. Natural history of chronic obstructive pulmonary disease exacerbations in a general practice-based population with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;198(4):464–471. doi:10.1164/rccm.201710-2029OC
   PubMed Web of Science ®Google Scholar
• Adibi A, Sin DD, Safari A, et al. The Acute COPD Exacerbation Prediction Tool (ACCEPT): a modelling study. Lancet Respir Med. 2020;8(10):1013–1021. doi:10.1016/S2213-2600(19)30397-2
   PubMed Web of Science ®Google Scholar
• GOLD Global Initiative for Chronic Obstructive Lung Disease - global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2017 report; 2017. Available from: https://goldcopd.org/wp-content/uploads/2017/02/wms-GOLD-2017-FINAL.pdf. Accessed June 27, 2022.
   Google Scholar
• Gedebjerg A, Szépligeti SK, Wackerhausen LH, et al. Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study. Lancet Respir Med. 2018;6(3):204–212. doi:10.1016/S2213-2600(18)30002-X
   PubMed Web of Science ®Google Scholar
• Agusti A, Edwards LD, Celli B, et al. Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort. Eur Respir J. 2013;42(3):636–646. doi:10.1183/09031936.00195212
   PubMed Web of Science ®Google Scholar
• Punekar YS, Mullerova H, Small M, et al. Prevalence and burden of dyspnoea among patients with chronic obstructive pulmonary disease in five European countries. Pulm Ther. 2016;2(1):59–72. doi:10.1007/s41030-016-0011-5
   Google Scholar
• Sansbury LB, Rothnie KJ, Bains C, Compton C, Anley G, Ismaila AS. Healthcare, medication utilization and outcomes of patients with COPD by GOLD classification in England. Int J Chron Obstruct Pulmon Dis. 2021;16:2591–2604. doi:10.2147/COPD.S318969
   PubMed Web of Science ®Google Scholar
• Martinez CH, Okajima Y, Murray S, et al. Impact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohort. Respir Res. 2014;15(1):62. doi:10.1186/1465-9921-15-62
   PubMed Web of Science ®Google Scholar
• GOLD Global Initiative for Chronic Obstructive Lung Disease - global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2023 report; 2022. Available from: https://goldcopd.org/2023-gold-report-2/. Accessed 17, February 2023.
   Google Scholar
• NICE Chronic obstructive pulmonary disease in over 16s: diagnosis and management; 2018. Available from: https://www.nice.org.uk/guidance/ng115/resources/chronic-obstructive-pulmonary-disease-in-over-16s-diagnosis-and-management-pdf-66141600098245. Accessed August 9, 2022.
   Google Scholar
• Price D, Miravitlles M, Pavord I, et al. First maintenance therapy for COPD in the UK between 2009 and 2012: a retrospective database analysis. NPJ Prim Care Respir Med. 2016;26:16061. doi:10.1038/npjpcrm.2016.61
   PubMed Web of Science ®Google Scholar
• Rothnie KJ, Müllerová H, Hurst JR, et al. Validation of the recording of acute exacerbations of COPD in UK primary care electronic healthcare records. PLoS One. 2016;11(3):e0151357. doi:10.1371/journal.pone.0151357
   PubMed Web of Science ®Google Scholar
• Rothnie KJ, Müllerová H, Thomas SL, et al. Recording of hospitalizations for acute exacerbations of COPD in UK electronic health care records. Clin Epidemiol. 2016;8:771–782. doi:10.2147/CLEP.S117867
   PubMed Web of Science ®Google Scholar
• Hastie A, Quibrera PM, Couper D, et al. Neither baseline blood nor sputum eosinophils predict future exacerbations in the SPIROMICS cohort. Eur Respir J. 2022;60(suppl 66):959. doi:10.1183/13993003.congress-2022.959
   Google Scholar
• Worth H, Buhl R, Criee CP, Kardos P, Guckel E, Vogelmeier CF. In ‘real world’ patients with COPD, exacerbation history, and not blood eosinophils, is the most reliable predictor of future exacerbations. Respir Res. 2023;24(1):2. doi:10.1186/s12931-023-02311-x
   PubMed Web of Science ®Google Scholar
• Løkke A, Hilberg O, Lange P, et al. Disease trajectories and impact of one moderate exacerbation in GOLD B COPD patients. Int J Chron Obstruct Pulmon Dis. 2022;17:569–578. doi:10.2147/COPD.S344669
   PubMed Web of Science ®Google Scholar
• Roche N, Devillier P, Berger P, et al. Individual trajectory-based care for COPD: getting closer, but not there yet. ERJ Open Res. 2021;7(4):00451–02021. doi:10.1183/23120541.00451-2021
   PubMedGoogle Scholar
• Steyerberg EW, Eijkemans MJ, Van Houwelingen JC, Lee KL, Habbema JD. Prognostic models based on literature and individual patient data in logistic regression analysis. Stat Med. 2000;19(2):141–160. doi:10.1002/(SICI)1097-0258(20000130)19:2<141::AID-SIM334>3.0.CO;2-O
   PubMed Web of Science ®Google Scholar
• Vestbo J, Hurd SS, Rodriguez-Roisin R. The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD)–why and what? Clin Respir J. 2012;6(4):208–214. doi:10.1111/crj.12002
   PubMed Web of Science ®Google Scholar